Internal Reference Number: FOI_9524
Date Request Received: 07/07/2026 00:00:00
Date Request Replied To: 21/07/2026 00:00:00
This response was sent via: By Email
Request Summary: Oncology Gastro Cancer
Request Category: Researcher
| Question Number 1: How many patients were treated in the last 3 months with any systemic anti-cancer therapies for Gastric cancer or cancer of the Gastro-Oesophageal Junction? | |
| Answer To Question 1: 26 | |
| Question Number 2: How many patients were treated in the past 3 months for gastric cancer (any stage) with: • CAPOX (Capecitabine with Oxaliplatin) • FOLFOX (Folinic acid, Fluorouracil and Oxaliplatin) • Lonsurf (Trifluridine - tipiracil) • Nivolumab in combination with Platinum (Cisplatin or Oxaliplatin) and Fluoropyrimidine (5-Fluorouracil or Capecitabine) • Pembrolizumab (any formulation) in combination with Platinum (Cisplatin or Oxaliplatin) and Fluoropyrimidine (5-Fluorouracil or Capecitabine) • Pembrolizumab (395 mg or 790mg solution for injection only) in combination with Platinum (Cisplatin or Oxaliplatin) and Fluoropyrimidine (5-Fluorouracil or Capecitabine) • Zolbetuximab (Vyloy) • Any other systemic anti-cancer therapy • Palliative care only • Trastuzumab in combination with cisplatin and capecitabine (or 5-fluorouracil) • Taxanes (e.g. docetaxel, paclitaxel) • Irinotecan Chemotherapy | |
| Answer To Question 2: How many patients were treated in the past 3 months for gastric cancer (any stage) with: • CAPOX (Capecitabine with Oxaliplatin)less than 5 • FOLFOX (Folinic acid, Fluorouracil and Oxaliplatin) less than 5 • Lonsurf (Trifluridine - tipiracil) less than 5 • Nivolumab in combination with Platinum (Cisplatin or Oxaliplatin) and Fluoropyrimidine (5-Fluorouracil or Capecitabine) 0 • Pembrolizumab (any formulation) in combination with Platinum (Cisplatin or Oxaliplatin) and Fluoropyrimidine (5-Fluorouracil or Capecitabine) less than 5 • Pembrolizumab (395 mg or 790mg solution for injection only) in combination with Platinum (Cisplatin or Oxaliplatin) and Fluoropyrimidine (5-Fluorouracil or Capecitabine) 0 • Zolbetuximab (Vyloy)0 • Any other systemic anti-cancer therapy less than 5 • Palliative care only less than 5 • Trastuzumab in combination with cisplatin and capecitabine (or 5-fluorouracil) 0 • Taxanes (e.g. docetaxel, paclitaxel) 0 • Irinotecan Chemotherapy 0 | |
| Question Number 3: How many patients were treated in the past 3 months for cancer of the gastro-oesophageal junction (any stage) with: • CAPOX (Capecitabine with Oxaliplatin) • FOLFOX (Folinic acid, Fluorouracil and Oxaliplatin) • Lonsurf (Trifluridine - tipiracil) • Nivolumab in combination with Platinum (Cisplatin or Oxaliplatin) and Fluoropyrimidine (5-Fluorouracil or Capecitabine) • Pembrolizumab (any formulation) in combination with Platinum (Cisplatin or Oxaliplatin) and Fluoropyrimidine (5-Fluorouracil or Capecitabine) • Pembrolizumab (395 mg or 790mg solution for injection only) in combination with Platinum (Cisplatin or Oxaliplatin) and Fluoropyrimidine (5-Fluorouracil or Capecitabine) • Zolbetuximab (Vyloy) • Any other systemic anti-cancer therapy • Palliative care only • Trastuzumab in combination with cisplatin and capecitabine (or 5-fluorouracil) • Taxanes (e.g. docetaxel, paclitaxel) • Irinotecan Chemotherapy | |
| Answer To Question 3: • CAPOX (Capecitabine with Oxaliplatin)less than 5 • FOLFOX (Folinic acid, Fluorouracil and Oxaliplatin)less than 5 • Lonsurf (Trifluridine - tipiracil)less than 5 • Nivolumab in combination with Platinum (Cisplatin or Oxaliplatin) and Fluoropyrimidine (5-Fluorouracil or Capecitabine)0 • Pembrolizumab (any formulation) in combination with Platinum (Cisplatin or Oxaliplatin) and Fluoropyrimidine (5-Fluorouracil or Capecitabine)7 • Pembrolizumab (395 mg or 790mg solution for injection only) in combination with Platinum (Cisplatin or Oxaliplatin) and Fluoropyrimidine (5-Fluorouracil or Capecitabine)less than 5 • Zolbetuximab (Vyloy) 0 • Any other systemic anti-cancer therapy 10 • Palliative care only less than 5 • Trastuzumab in combination with cisplatin and capecitabine (or 5-fluorouracil) 0 • Taxanes (e.g. docetaxel, paclitaxel)0 • Irinotecan Chemotherapy less than 5 | |
| To return to the list of all the FOI requests please click here |
Our staff at 91Ó°ÊÓ District Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.
